Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
P. Bottini, L. Taranto Montemurro, C. Andreoli, M. Bettinzoli, M. Novali, E. Roca, L. Corda, M. Bentivoglio, C. Tantucci (Perugia, Brescia, Italy). Long-term effect of CPAP on systemic arterial hypertension development and control in a single cohort of 422 OSAH patients. Eur Respir J 2010; 36: Suppl. 54, 939

Member's Comments

No comment yet.

Related content which might interest you: Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 CPAP treatment reduce blood pressure in patients with recent diagnosis of systemic hypertension and obstructive sleep apnoea -hypopnoea (OSAH). A controlled study Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Nocturnal BP pattern and cardiovascular risk in a group of patients with moderate-severe OSAS. Evaluation of the effect of CPAP treatment Source: Eur Respir J 2007; 30: Suppl. 51, 335s Year: 2007 Positive effect of CPAP treatment on the control of difficult-to-treat hypertension Source: Eur Respir J 2007; 29: 951-957 Year: 2007 Sleep apnoea and systemic hypertension Source: Eur Respir Mon 2010; 50: 150-173 Year: 2010 Effect of long-term oxygen therapy on exercise capacity and quality of life in exercise-desaturating patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomized-sham-controlled cross-over trial Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Effect of selexipag on long-term outcomes in key subgroups of patients with pulmonary arterial hypertension (PAH): GRIPHON study results Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 Effects of continuous positive airway pressure (nCPAP) on pulmonary hemodynamics in COPD patients with overlap syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 568s Year: 2004 Long term effects of CPAP in blood pressure in nonsleepy hypertensive OSA patients Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Successful pregnancy outcome in patients with pulmonary arterial hypertension receiving prostayclin therapy Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004 Noninvasive positive pressure ventilation (NPPV) in the treatment of acute respiratory failure in patients with morbid obesity: a prospective cohort study Source: Eur Respir J 2004; 24: Suppl. 48, 313s Year: 2004 The need of higher CPAP pressure in a population with obstructive sleep apnea (OSA) and refractory hypertension (RHT) versus controlled hypertension-a retrospective study Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Influence of continuous positive airway pressure therapy on endothelial function and blood pressure in patients with arterial hypertension and obstructive sleep apnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients Source: Eur Respir J 2006; 27: 1229-1235 Year: 2006 No reduction of blood pressure with CPAP in non-sleepy hypertensive OSA patients Source: ISSN=ISSN 1810-6838, ISBN=, page=193 Year: 2006 Effect of the continuous positive airway pressure in apneic patients with resistant hypertension: results from the randomized controlled RHOOSAS study Source: International Congress 2017 – CPAP therapy Year: 2017 Sildenafil effects on 1-year survival of patients with idiopathic pulmonary arterial hypertension (IPAH) Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005 Long-term riociguat treatment towards implementing a targeted treatment strategy in patients with idiopathic pulmonary arterial hypertension Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020 The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020